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Abstract

Discussion

1. Expression

Both breast and prostate tumors can be surgically removed when in

Optimization of the expression reaction is shown under “1. Expression.”
From this, the highest yield of the inflammatory cytokine construct (70

Stages I, II, and III. Once the tumor undergoes metastasis (stage IV),
survival rates drop; and the surgical removal of the primary tumor will no

kDa) was found when 0.5 mM IPTG was used for induction and the

longer be sufficient for treatment. An inflammatory cytokine (IC), a protein

reaction incubated overnight at 30 °C. The amylose column shows a
successful reduction of other cell components and almost complete

that acts as a signal molecule in inflammation, has been identified as a

isolation of the inflammatory cytokine construct.

primary signal in metastasis. Therefore, targeting the inflammatory
cytokine with a small molecule inhibitor (SMI) will prevent

Future Work

metastasis from occurring. Structure-based drug design
requires an accurate measurement of how well the SMI
can bind to the inflammatory cytokine. This binding
requires the expression and purification of the
inflammatory protein with high purity and accuracy. The

Recent efforts aim to improve 3C cleavage reaction and

4. Size Exclusion
Chromatography

2. Amylose Column

increase yield after Ni-NTA column. Future work could
include using a construct with a TEV cleavage site in
place of the 3C cleavage site.

construct designed for the purification consists of the
cytokine protein attached to a maltose-binding protein
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(MBP) and six histidines. The MBP serves to increase
solubility; however, it also is electrostatically attracted to

70 kDa

the inflammatory cytokine. To ensure efficient separation
of these two proteins, a six-histidine tag is attached to
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